Hair follicle-derived mesenchymal stem cells (HF-MSCs) show considerable therapeutic
potential for liver cirrhosis (LC). To improve the effectiveness of naïve HF-MSC treatments on …

Liver cirrhosis (LC) involves multiple systems throughout the body, and patients with LC
often die of multiple organ failure. However, few drugs are useful to treat LC. Hair follicle …

Researchers have shown that bone mesenchymal stem cells (BMSCs) can alleviate the
progression of liver cirrhosis; however, it is unclear how exactly BMSCs function to cure liver …

Background Few effective anti-fibrotic therapies are currently available for liver cirrhosis.
Mesenchymal stromal cells (MSCs) ameliorate liver fibrosis and contribute to liver …

Background Liver fibrosis resulting from chronic liver injury is one of the major causes of
mortality worldwide. Stem cell-secreted secretome has been evaluated for overcoming the …

Acute liver failure (ALF) is a life‐threatening condition. Cell‐based and cell‐free‐based
therapies have proven to be effective in treating ALF; however, their clinical application is …

Background Orthotopic liver transplantation is the only effective treatment for liver failure but
limited with shortage of available donor organs. Recent studies show promising results of …

Background Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have
garnered considerable attention as prospective modalities of treatment for liver fibrosis (LF) …

Chronic Liver fibrosis may progress to liver cirrhosis and hepatocellular carcinoma (HCC),
hence cause a substantial global burden. However, effective therapies for blocking fibrosis …

Metabolic‐associated fatty liver disease (MAFLD) is currently the most common chronic liver
disease worldwide. However, its pathophysiological mechanism is complicated, and …